Research ArticleArticle
Identification of Overlapping but Differential Binding Sites for the High-Affinity CXCR3 Antagonists NBI-74330 and VUF11211
Danny J. Scholten, Luc Roumen, Maikel Wijtmans, Marlies C. A. Verkade-Vreeker, Hans Custers, Michael Lai, Daniela de Hooge, Meritxell Canals, Iwan J. P. de Esch, Martine J. Smit, Chris de Graaf and Rob Leurs
Molecular Pharmacology January 2014, 85 (1) 116-126; DOI: https://doi.org/10.1124/mol.113.088633
Danny J. Scholten
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Luc Roumen
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Maikel Wijtmans
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Marlies C. A. Verkade-Vreeker
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Hans Custers
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Michael Lai
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Daniela de Hooge
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Meritxell Canals
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Iwan J. P. de Esch
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Martine J. Smit
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Chris de Graaf
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Rob Leurs
Division of Medicinal Chemistry, Faculty of Science, Amsterdam Institute for Molecules, Medicines, and Systems, VU University Amsterdam, Amsterdam, The Netherlands
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Allosteric Antagonist Binding to the Chemokine Receptor CXCR3
Danny J. Scholten, Luc Roumen, Maikel Wijtmans, Marlies C. A. Verkade-Vreeker, Hans Custers, Michael Lai, Daniela de Hooge, Meritxell Canals, Iwan J. P. de Esch, Martine J. Smit, Chris de Graaf and Rob Leurs
Molecular Pharmacology January 1, 2014, 85 (1) 116-126; DOI: https://doi.org/10.1124/mol.113.088633
Research ArticleArticle
Allosteric Antagonist Binding to the Chemokine Receptor CXCR3
Danny J. Scholten, Luc Roumen, Maikel Wijtmans, Marlies C. A. Verkade-Vreeker, Hans Custers, Michael Lai, Daniela de Hooge, Meritxell Canals, Iwan J. P. de Esch, Martine J. Smit, Chris de Graaf and Rob Leurs
Molecular Pharmacology January 1, 2014, 85 (1) 116-126; DOI: https://doi.org/10.1124/mol.113.088633
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement